Smad7 Modulates Epidermal Growth Factor Receptor Turnover through Sequestration of c-Cbl

Area of Science:

• Cell Biology
• Molecular Biology
• Dermatology

Background:

• Epidermal growth factor (EGF) is crucial for cellular functions, but its signaling requires strict regulation for homeostasis.
• Aberrant EGF signaling is linked to uncontrolled cell proliferation and tumorigenesis.
• Smad7, typically an inhibitor of TGF-β signaling, exhibits context-dependent roles in cell proliferation and transformation.

Purpose of the Study:

• To investigate the novel role of Smad7 in regulating Epidermal Growth Factor Receptor (EGFR) signaling pathways.
• To elucidate the mechanism by which Smad7 influences EGFR activity and stability in keratinocytes and skin tissues.

Main Methods:

• Overexpression of Smad7 in human HaCaT keratinocytes and mouse skin tissues.
• Analysis of EGFR ubiquitination and degradation following EGF stimulation.
• Investigation of the interaction between Smad7 and the E3 ubiquitin ligase c-Cbl using specific Smad7 regions (MH1, MH2).
• Assessment of the effect of wild-type Smad7, Smad6, and mutant Smad7 on c-Cbl/EGFR complex formation.

Main Results:

• Overexpression of Smad7 elevated EGFR activity in HaCaT cells and mouse skin.
• Smad7 impaired ligand-induced ubiquitination and degradation of EGFR by interacting with c-Cbl.
• The C-terminal MH2 region of Smad7 was critical for inhibiting EGFR ubiquitination via c-Cbl.
• Wild-type Smad7, but not Smad6 or mutant Smad7, destabilized the EGF-induced c-Cbl/EGFR complex.

Conclusions:

• Smad7 acts as a novel promoter of sustained EGFR signaling in keratinocytes and skin.
• By reducing EGFR ubiquitination and degradation, Smad7 prolongs EGF signal transduction.
• This mechanism may contribute to cell proliferation and potentially skin tumorigenesis.